My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Advanced glycation end products in nondiabetic patients with coronary artery disease.

    Kanauchi M, Tsujimoto N, Hashimoto T.

    Diabetes Care. 2001 Sep;24(9):1620-3.PMID: 11522709 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Demonstration of insulin resistance in coronary artery disease documented with angiography.

    Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y.

    Diabetes Care. 1996 Jan;19(1):1-7.PMID: 8720524 [PubMed - indexed for MEDLINE]Related articles

    3.

    Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

    Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS.

    Diabetes Care. 2002 Jun;25(6):1055-9.PMID: 12032114 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Products of advanced glycation in patients with type 2 diabetes and vascular disease.

    Turk Z, Sesto M, Skodlar J, Ferencak G, Pokupec R, Turk N, Stavljenić-Rukavina A.

    Ann Clin Biochem. 2003 Sep;40(Pt 5):552-9.PMID: 14503994 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients.

    Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H.

    Heart. 2001 Jan;85(1):87-91.PMID: 11119472 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

    Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ.

    Diabetologia. 2006 Nov;49(11):2756-62. Epub 2006 Sep 13.PMID: 16969649 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.

    Tan KC, Chow WS, Tam S, Bucala R, Betteridge J.

    Diabetes Care. 2004 Jan;27(1):223-8.PMID: 14693993 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.

    Aso Y, Inukai T, Tayama K, Takemura Y.

    Acta Diabetol. 2000;37(2):87-92.PMID: 11194933 [PubMed - indexed for MEDLINE]Related articles

    9.

    A novel advanced glycation index and its association with diabetes and microangiopathy.

    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.

    Metabolism. 2005 Aug;54(8):1002-7.PMID: 16092048 [PubMed - indexed for MEDLINE]Related articles

    10.

    The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.

    Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M.

    Diabetes Care. 2007 Sep;30(9):2374-80. Epub 2007 Jun 26.PMID: 17595351 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.

    Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH.

    Metabolism. 2007 Feb;56(2):199-205.PMID: 17224333 [PubMed - indexed for MEDLINE]Related articles

    12.

    Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

    Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Sato A, Imaizumi T.

    Diabetes Metab Res Rev. 2007 Jul;23(5):368-71.PMID: 17024691 [PubMed - indexed for MEDLINE]Related articles

    13.

    Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population.

    Yamagishi S, Adachi H, Takeuchi M, Enomoto M, Furuki K, Matsui T, Nakamura K, Imaizumi T.

    Horm Metab Res. 2007 Nov;39(11):845-8.PMID: 17992643 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

    Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF.

    Diabetes Care. 1999 Sep;22(9):1543-8.PMID: 10480523 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study.

    Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M.

    Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):815-20. Epub 2005 Feb 3.PMID: 15692098 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients.

    Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K.

    Heart Vessels. 2008 Jan;23(1):9-15. Epub 2008 Feb 14.PMID: 18273540 [PubMed - indexed for MEDLINE]Related articles

    17.

    Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis.

    Kowalska I, Prokop J, Bachórzewska-Gajewska H, Telejko B, Kinalskal I, Kochman W, Musial W.

    Diabetes Care. 2001 May;24(5):897-901.PMID: 11347751 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

    Galler A, Müller G, Schinzel R, Kratzsch J, Kiess W, Münch G.

    Diabetes Care. 2003 Sep;26(9):2609-15.PMID: 12941727 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.

    Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF.

    Cardiovasc Diabetol. 2006 Dec 20;5:27.PMID: 17178005 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

    Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M.

    Diabetes. 2003 Feb;52(2):239-43.PMID: 12540592 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity